
Berkeley Catalyst Fund (BCF)
Description
Berkeley Catalyst Fund (BCF) is an early-stage venture capital firm deeply rooted in the innovation ecosystem of the University of California, Berkeley. Established with a mission to commercialize groundbreaking research and technologies emerging from UC Berkeley and the broader Bay Area, BCF serves as a crucial bridge between academic discovery and market-ready solutions. The firm leverages its unique affiliation with one of the world's leading public universities, providing portfolio companies with unparalleled access to a vast network of faculty, alumni, and scientific expertise, alongside strategic capital.
BCF primarily targets seed and Series A stage companies that are developing disruptive technologies in sectors such as deep tech, life sciences, advanced materials, cleantech, and artificial intelligence. They seek ventures that possess strong intellectual property, a clear path to commercialization, and a passionate founding team. The fund's investment thesis centers on identifying and nurturing companies that can address significant market needs with science-backed innovations, often stemming directly from university labs. Their hands-on approach extends beyond capital, offering strategic guidance, operational support, and connections to industry leaders.
The firm typically deploys initial investments ranging from $250,000 to $1,000,000, demonstrating their commitment to supporting nascent ventures at critical junctures. With a reported fund size for BCF II around $50 million, they possess the capacity for follow-on investments to support portfolio companies through subsequent growth stages. BCF's strategy emphasizes long-term partnerships, aiming to help founders navigate the complexities of scaling deep technology companies from concept to market leadership. Their focus on the Berkeley ecosystem ensures a pipeline of high-potential, research-driven startups poised for significant impact.
Investor Profile
Berkeley Catalyst Fund (BCF) has backed more than 37 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 24% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Ireland.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $250K – $1M.
Stage Focus
- Series A (32%)
- Seed (27%)
- Series B (19%)
- Series Unknown (11%)
- Series C (5%)
- Pre Seed (3%)
- Debt Financing (3%)
Country Focus
- United States (97%)
- Ireland (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Medical Device
- Manufacturing
- Therapeutics
- Genetics
- Information Technology
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.